The GLP is committed to full transparency. Download and review our Annual Report.

Stem cells to optimize match between patient and medication

| May 24, 2012

One of the biggest barriers to the development of new medical therapies is the cost of taking a new drug from a concept in a lab to a proven treatment. Estimates of these costs range from $100-million to $1.2-billion for each new drug that makes it to market, and a substantial chunk of this funding is consumed by establishing that a drug is both safe and effective. A new initiative combining breakthroughs in research, private sector support, and a non-profit committed to regenerative medicine is dedicated to improving this process.

View the original article here: Stem cells to optimize match between patient and medication – National Post

The GLP aggregated and excerpted this article to reflect the diversity of news, opinion, and analysis. Click the link above to read the full, original article.
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend